Attention-Deficit/Hyperactivity Disorder
Conditions
Interventions
Healthy control group:NA
ADHA experimental group:NA
Sponsors
Chengdu Second People's Hospital
Eligibility
Sex/Gender
All
Age
7 Years to 18 Years
Inclusion criteria
Inclusion criteria: 1: Children and young people aged between 7 and 18; 2: Participants and legal guardians sign written informed consent to confirm their voluntary participation in the study; 3: Normal visual and auditory function (corrected visual acuity >=1.0, pure tone audiometry threshold =4 weeks; 6: There was no known diagnosis of specific diseases other than ADHD.
Exclusion criteria
Exclusion criteria: 1: young persons receiving education in special schools; 2: combined with other neurodevelopmental disorders (such as autism spectrum disorder, intellectual disability); 3: A history of chronic neurological diseases (such as epilepsy) or serious other diseases (such as cancer); 4: Participating in other interventional clinical trials within the past 1 month; 5: Presence of photoallergy or metal implants.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| adverse events;integrated value of oxygenated hemoglobin concentration; | — |
Secondary
| Measure | Time frame |
|---|---|
| ADHD-RS-IV questionnaire; | — |
Countries
China
Contacts
Public ContactYang Ying
Chengdu Second People's Hospital
Outcome results
None listed